Depression and anxiety in oncology: The psychiatrist's perspective

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 8, 2001, Pages 58-63

  Berard, Ray M F ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTINEOPLASTIC AGENT; DESIPRAMINE; FLUOXETINE; MIANSERIN; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; HUMAN; NAUSEA; ONCOLOGY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEX RATIO; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PAROXETINE; PERSONALITY INVENTORY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHIATRY; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035002179     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 1996;30:109-116
2. Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer Care 1998;7:181-191
3. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993;50:681-689
4. Massie MJ, Holland JC. Depression and the cancer patient. J Clin Psychiatry 1990;51(7, suppl):12-17
5. Razavi D, Delvaux N, Farvacques C, et al. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 1990;156:79-83
6. McDaniel JS, Musselman DL, Porter MR, et al. Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52: 89-99
7. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370
8. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 1991;64:353-356
9. Carroll BT, Kathol RG, Noyes R Jr, et al. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 1993;15:69-74
10. Snaith P. What do depression ratings measure? Br J Psychiatry 1993;163: 293-298
11. Purohit DR, Navlakha PL, Modi RS, et al. The role of antidepressants in hospitalised cancer patients: a pilot study. J Assoc Physicians India 1978; 26:245-248
12. Rifkin A, Reardon G, Saris S, et al. Trimipramine in physical illness with depression. J Clin Psychiatry 1985;46(2, pt 2):4-8
13. Maguire P, Hopwood P, Tarrier N, et al. Treatment of depression in cancer patients. Acta Psychiatr Scand Suppl 1985;320:81-84
14. van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients: a placebo-controlled study of mianserin. Br J Psychiatry 1996;169:440-443
15. Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl 1985;320:85-92
16. Popkin MK, Cailles AL, Mackenzie TB. The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 1985;42:1160-1163
17. Eija K, Tiina T, Pertti NJ. Amitriplyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996;64:293-302
18. Ravindran AV, Judge R, Hunter BN, et al. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. J Clin Psychiatry 1997;58:112-118
19. Lewis-Hall FC, Wilson MG, Tepner RG, et al. Fluoxetine vs tricyclic antidepressants in women with major depressive disorder. J Womens Health 1997;6:337-343
20. Cooper GL. The safety of fluoxetine: an update. Br J Psychiatry Suppl 1988;3:77-86
21. Hirschfeld RMA. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry 1999;60:326-335
22. Razavi D, Allilaire JF, Smith M, et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996;94:205-210
23. Holland JC, Romano SJ, Heiligenstein JH, et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998;7:291-300
24. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat. In press
25. Sellick SM, Crooks DL. Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psycho-oncology 1999;8:315-333
26. Greer S, Moorey S, Baruch JD, et al. Adjuvant psychological therapy for patients with cancer a prospective randomised trial. BMJ 1992;304: 675-680
27. Edgar L, Rosberger Z, Nowlis D. Coping with cancer during the first year after diagnosis, assessment and intervention. Cancer 1992;69:817-828
28. Burton MV, Parker RW, Farrell A, et al. A randomized controlled trial of preoperative psychological preparation for mastectomy. Psycho-oncology 1992;4:1-19
29. Watson CP. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994;9:392-405
30. Korzeniewska-Rybicka I, Plaznik A. Analgesic effect of antidepressant drugs. Pharmacol Biochem Behav 1998;59:331-338
31. Breitbart W. Psychotropic adjuvant analgesics for pain in cancer and AIDS. Psycho-oncology 1998;7:333-345
32. Roth AJ, Scher HI. Sertraline relieves hot flushes secondary to medical castration as treatment of advanced prostate cancer. Psycho-oncology 1998;7: 129-132